Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00057
|
|||||
| Drug Name |
Aminolevulinic acid
|
|||||
| Synonyms |
5-ALA; 5-Amino-4-oxopentanoate; 5-Amino-4-oxopentanoic acid; 5-Amino-4-oxovaleric acid; 5-Aminolevulinate; 5-Aminolevulinic acid; 5-amino-levulinate; Aladerm; Aminolevulinate; Aminolevulinic; Delta-ALA; Delta-aminolevulinic acid; Kerastick; Levulinic acid, 5-amino-(8CI); Pentanoic acid, 5-amino-4-oxo-(9CI)
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Photodynamic therapy [ICD11: EK90.0] | Approved | [1] | |||
| Therapeutic Class |
Photosensitizing Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C5H9NO3
|
|||||
| Canonical SMILES |
C(CC(=O)O)C(=O)CN
|
|||||
| InChI |
InChI=1S/C5H9NO3/c6-3-4(7)1-2-5(8)9/h1-3,6H2,(H,8,9)
|
|||||
| InChIKey |
ZGXJTSGNIOSYLO-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 106-60-5
|
|||||
| Pharmaceutical Properties | Molecular Weight | 131.13 | Topological Polar Surface Area | 80.4 | ||
| Heavy Atom Count | 9 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
-3.8
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103182993
, 104098261
, 104170099
, 104293958
, 108134724
, 11342129
, 11362312
, 11364476
, 11367038
, 11369600
, 11372726
, 11374315
, 11377762
, 11485579
, 11487714
, 11489478
, 11491469
, 11492433
, 11495396
, 118693344
, 121362447
, 124799829
, 125662954
, 126523837
, 126579879
, 126630164
, 15170674
, 24438516
, 3719
, 46506856
, 47589325
, 47662632
, 50002793
, 50122683
, 51031867
, 51091887
, 53789366
, 5427092
, 56320695
, 56322917
, 57319985
, 8144107
, 8150474
, 841472
, 85083671
, 85291378
, 92298402
, 92712186
, 93166418
, 99451455
|
|||||
| ChEBI ID |
ChEBI:17549
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | PAT1 | Transporter Info | Proton-coupled amino acid transporter 1 | Substrate | [2] | |
| PEPT1 | Transporter Info | Peptide transporter 1 | Substrate | [3] | ||
| PEPT2 | Transporter Info | Peptide transporter 2 | Substrate | [4] | ||
| Drug-Transporter Activity Data | ||||||
| Drug-Transporter Activity Data | PAT1 | Transporter Info | Km = 6800 microM | Monkey kidney fibroblast-like cell (COS)7-hPAT1 | [2] | |
| PEPT1 | Transporter Info | Km = 394 microM | Oocytes-PEPT1 | [5] | ||
| PEPT1 | Transporter Info | Km = 1600 microM | Oocytes-PEPT1 | [3] | ||
| PEPT2 | Transporter Info | Km = 227 microM | Oocytes-PEPT2 | [5] | ||
| References | ||||||
| 1 | Aminolevulinic acid was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Delta-aminolevulinic acid is a substrate for the amino acid transporter SLC36A1 (hPAT1). Br J Pharmacol. 2010 Mar;159(6):1339-53. | |||||
| 3 | Transport of the photodynamic therapy agent 5-aminolevulinic acid by distinct H+-coupled nutrient carriers coexpressed in the small intestine. J Pharmacol Exp Ther. 2010 Jan;332(1):220-8. | |||||
| 4 | PEPT2-mediated transport of 5-aminolevulinic acid and carnosine in astrocytes. Brain Res. 2006 Nov 29;1122(1):18-23. | |||||
| 5 | Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications. J Clin Invest. 1998 Jun 15;101(12):2761-7. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.